Ranadheera Charlene, Antonation Kym, Corbett Cindi
Health Security and Response Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.
Can Commun Dis Rep. 2023 May 1;49(5):175-179. doi: 10.14745/ccdr.v49i05a02.
To help accommodate the surge in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) clinical testing due to the coronavirus disease 2019 pandemic, the decentralization of testing from provincial public health laboratories to regional laboratories and private facilities was necessary. To further support the growing number of test sites in Canada, the National Microbiology Laboratory developed a proficiency test program for the detection of SARS-CoV-2 using nucleic acid amplification tests and administered it under an arm of the Canadian Laboratory Response Network (CLRN). Since its conception in May 2020, CLRN has conducted three proficiency test schemes, from May 2020 to June 2021, and has observed an increase in participation of more than 400%. This article will explore the evolution of CLRN's SARS-CoV-2 Proficiency Test Program and its support of the Canadian pandemic response.
为应对2019冠状病毒病大流行导致的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）临床检测激增的情况，有必要将检测工作从省级公共卫生实验室下放到区域实验室和私人机构。为进一步支持加拿大不断增加的检测点，国家微生物实验室制定了一项使用核酸扩增检测来检测SARS-CoV-2的能力验证测试计划，并在加拿大实验室应对网络（CLRN）的一个部门管理下实施该计划。自2020年5月设立以来，CLRN在2020年5月至2021年6月期间开展了三项能力验证测试方案，参与率增长超过400%。本文将探讨CLRN的SARS-CoV-2能力验证测试计划的演变及其对加拿大应对疫情的支持。
